A
Arbutus Biopharma Corporation (ABUS)
NMS – Real Time Price. Currency in USD
4.58
+0.17 (3.85%)
At close: Jun 26, 2026, 4:00 PM EDT
4.65
+0.07 (1.53%)
After-hours: Jun 26, 2026, 6:14 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
4.58
+0.17 (3.85%)
At close: Jun 26, 2026, 4:00 PM EDT
4.65
+0.07 (1.53%)
After-hours: Jun 26, 2026, 6:14 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $23.7M significantly exceed its total debt $3.9M, ensuring strong financial flexibility
Total current assets $277.0M exceed Total current liabilities $5.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (9948x) indicates the company easily manages its debt payments
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 54.26 | 6.05 | 10 | |
| Quick ratio | 54.26 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 9.0 | |
| Interest coverage | 9948.06 | -16.91 | 10 | |
| Weighted average score | 9.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 39M | 18M | 6M | 14M | 191M |
| Gross Profit | 38M | 17M | 5M | 14M | 191M |
| Operating Income | -63M | -78M | -70M | -27M | 155M |
| Net Income | -69M | -73M | -70M | -34M | 161M |
| EBITDA | -62M | -77M | -69M | -27M | 155M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -93.48 | -300 | 1.0 |
| Next quarter | 28.73 | 50 | 10 |
| Current year | 1186.66 | 541.18 | 10 |
| Next year | -98.51 | -112 | 1.0 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 16943.39 | 4617.97 | 8800 | 27.63 | 10 |
| Y/Y | 10054.54 | 791.9 | 769.23 | 54.15 | 10 |
| 3y average | 2.91 | 17.08 | 24.42 | -26.04 | 6.0 |
| 5y average | 64.55 | 8.11 | 26.97 | -12.56 | 6.8 |
| Weighted average score | 8.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |